Related Experiment Video
Updated: Feb 10, 2026

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells
Published on: May 24, 2014
TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis
Qiushi Wang1, Ge Gao1,2, Tianshun Zhang1
1The Hormel Institute, University of Minnesota, Austin, Minnesota.
Abstract:
Tumor necrosis factor receptor (TNFR)-associated factor 1 (TRAF1) is a unique TRAF protein that can interact directly or indirectly with multiple TNFR family members, regulatory proteins, kinases, and adaptors that contribute to its diverse functions in specific tissues. However, the role of TRAF1 in non-small cell lung cancer (NSCLC) remains unknown. In this study, we report that TRAF1 is overexpressed in human lung cancer cells and tissues. TRAF1 expression level inversely correlated with patient survival probability. Loss of TRAF1 decelerated tumor invasion in a urethane-induced lung carcinogenesis mouse model. Furthermore, TRAF1 expression affected TRAF2-mediated BRAF Lys48-linked ubiquitination, which was followed by the inhibition of growth and differentiation, and the induction of death in lung cancer cells. Overall, our work suggests that TRAF1 plays a novel role in the regulation of the BRAF/MEK/ERK signaling pathway in NSCLC and offers a candidate molecular target for lung cancer prevention and therapy.Significance: These findings identify TRAF1 as a new therapeutic target for NSCLC. Cancer Res; 78(14); 3982-94. ©2018 AACR.
Insights
Tumor necrosis factor receptor-associated factor 1 (TRAF1) is overexpressed in non-small cell lung cancer (NSCLC). TRAF1 promotes tumor invasion and affects cell death, indicating its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor necrosis factor receptor (TNFR)-associated factor 1 (TRAF1) is a protein involved in various cellular functions.
- The specific role of TRAF1 in non-small cell lung cancer (NSCLC) has not been previously elucidated.
Purpose of the Study:
- To investigate the role of TRAF1 in the development and progression of NSCLC.
- To determine if TRAF1 could serve as a potential therapeutic target for NSCLC.
Main Methods:
- Analysis of TRAF1 expression in human lung cancer tissues and cell lines.
- In vivo studies using a mouse model of lung carcinogenesis.
- Investigation of TRAF1's effect on the BRAF/MEK/ERK signaling pathway and TRAF2-mediated ubiquitination.
Main Results:
- TRAF1 was found to be overexpressed in NSCLC tissues and cells.
- Higher TRAF1 expression correlated with lower patient survival rates.
- Loss of TRAF1 reduced tumor invasion in a mouse model.
- TRAF1 influences BRAF ubiquitination, impacting cell growth, differentiation, and death in lung cancer cells.
Conclusions:
- TRAF1 plays a significant role in NSCLC progression by regulating the BRAF/MEK/ERK pathway.
- TRAF1 represents a novel molecular target for NSCLC prevention and therapy.
Related Concept Videos
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
GTPases and their Regulation
Large G-proteins,...
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Critical Values
Lung Capacity

